Sustained HPV-16 and 18 Antibody Levels Through 5.5 Years in Women Vaccinated with the HPV-16/18 L1 VLP AS04 Candidate Vaccine
Diane M. Harper
United States of America
Disclosure : - Research support from Sanofi Pasteur/Aventis and GSK
- Consultant Sanofi Pasteur/Aventis and GSK, specifically for the HPV Vaccines Trials
[More]
[Less]
17 slide(s) – 00:05:57 – English – 2007-10-31
|